share_log

BMO Capital Upgrades Amgen to Outperform, Raises Price Target to $326

BMO Capital Upgrades Amgen to Outperform, Raises Price Target to $326

BMO Capital将安进上调至跑赢大盘,将目标股价提高至326美元
Benzinga ·  2023/12/19 05:13

BMO Capital analyst Evan David Seigerman upgrades Amgen (NASDAQ:AMGN) from Market Perform to Outperform and raises the price target from $286 to $326.

BMO Capital分析师埃文·戴维·塞格曼将安进(纳斯达克股票代码:AMGN)从市场表现上调至跑赢大盘,并将目标股价从286美元上调至326美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发